Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4212491
Max Phase: Preclinical
Molecular Formula: C45H58N8O10
Molecular Weight: 871.00
Molecule Type: Small molecule
Associated Items:
ID: ALA4212491
Max Phase: Preclinical
Molecular Formula: C45H58N8O10
Molecular Weight: 871.00
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC1(C)CC[C@]2(C(=O)N3CCN(c4cc(O/N=[N+](\[O-])N5CCOCC5)c([N+](=O)[O-])cc4[N+](=O)[O-])CC3)CC[C@]3(C)[C@H](C(=O)C=C4[C@@]5(C)C=C(C#N)C(=O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]2C1
Standard InChI: InChI=1S/C45H58N8O10/c1-40(2)10-12-45(13-11-44(7)37(29(45)26-40)33(54)24-36-42(5)25-28(27-46)38(55)41(3,4)35(42)8-9-43(36,44)6)39(56)49-16-14-48(15-17-49)30-23-34(32(52(59)60)22-31(30)51(57)58)63-47-53(61)50-18-20-62-21-19-50/h22-25,29,35,37H,8-21,26H2,1-7H3/b53-47-/t29-,35-,37-,42-,43+,44+,45-/m0/s1
Standard InChI Key: CJCPRUROHYKGBT-AKKLAZCWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 871.00 | Molecular Weight (Monoisotopic): 870.4276 | AlogP: 6.87 | #Rotatable Bonds: 7 |
Polar Surface Area: 227.89 | Molecular Species: ACID | HBA: 13 | HBD: 0 |
#RO5 Violations: 3 | HBA (Lipinski): 18 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 2.98 | CX Basic pKa: 1.19 | CX LogP: 5.12 | CX LogD: 6.16 |
Aromatic Rings: 1 | Heavy Atoms: 63 | QED Weighted: 0.12 | Np Likeness Score: 0.64 |
1. Kang F, Ai Y, Zhang Y, Huang Z.. (2018) Design and synthesis of new hybrids from 2-cyano-3,12-dioxooleana- 9-dien-28-oic acid and O2-(2,4-dinitrophenyl) diazeniumdiolate for intervention of drug-resistant lung cancer., 149 [PMID:29501947] [10.1016/j.ejmech.2018.02.062] |
Source(1):